The Singapore Screening Center conducts high-throughput screening to identify potential drug candidates against disease, using a library of over 300,000 chemical compounds. It today employs Agilent’s dual BioCel 1200 integrated program, which automates and coordinates the many processes of high-throughput screening, including compound management, assay plate planning and experiment replication, to ensure high-quality data while saving time and reducing the possibility of human mistake.According to a statement published on COPE’s site in January 2015, these efforts to hijack the scholarly review program were apparently orchestrated by organizations that first helped authors create or improve their scientific articles and then marketed them favorable peer testimonials.4 BioMed Central conducted a comprehensive investigation of most their recently published content articles and identified 43 that were published based on evaluations from fabricated reviewers. All these articles had been retracted in March 2015.